Documentation of the Efficacy of Desmopressin (MINIRIN Parenteral 4 Microgram/ml Solution for Injection) Within the Context of Surgical Procedures
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Desmopressin (Primary)
- Indications Platelet dysfunction
- Focus Therapeutic Use
- Acronyms RAPID
- Sponsors Ferring Pharmaceuticals
- 23 Jun 2016 Status changed from recruiting to completed.
- 21 Apr 2016 Planned number of patients changed from 200 to 30.
- 21 Apr 2016 Planned End Date changed from 1 Sep 2016 to 1 May 2016.